Skip to content

Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics

Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics (ALIVE-PD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01479062
Enrollment
339
Registered
2011-11-24
Start date
2014-02-28
Completion date
2015-12-31
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Obesity, Pre-diabetes

Keywords

behavior change, pre-diabetes, prevention, diabetes prevention, Hemoglobin A1c, glucose, physical activity, nutrition, email, web, obesity

Brief summary

The trial will test whether the Alive multi-channel delivery health behavior program can positively affect weight and glucose level in pre-diabetics.

Interventions

BEHAVIORALAlive-PD

Weekly email/web goal-setting intervention to improve physical activity, diet and weight loss for pre-diabetics, with additional phone support

BEHAVIORALUsual Care

Placebo Control

Sponsors

Palo Alto Medical Foundation
CollaboratorOTHER
Berkeley Analytics, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* at least one measurement in past 2 yrs of fasting plasma glucose of 100-125 mg/dl or impaired glucose tolerance * at least one measurement of body mass index (BMI) \>=27 in the past two years * age 40-79 * no use of diabetes medications within the past two years * member of Kaiser Permanente of Northern California (KPNC) for at least 2 years * live in a 25 mile radius of the KPNC Research Clinic in Oakland, CA

Exclusion criteria

* comorbidities that would contraindicate the gradual adoption of light/moderate physical activity, such as a recent cardiovascular event, severe chronic obstructive pulmonary disease, advanced arthritis, or poorly controlled hypertension

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in body weightat 3 months, 6 months and one yearMean weight loss and the proportion of subjects who achieve a 5% body weight loss at 3 and 6 months and maintain at 12 months
Change from baseline in diabetes risk markersat 3 months, 6 months and one yearChange in blood glucose level and hemoglobin A1c (HbA1c) as measured in clinic at 3 and 6 months and maintain at 12 months

Secondary

MeasureTime frameDescription
Change from baseline in physical activity and dietary factors3 months and 12 monthsExtent of change in physical activity and dietary factors as reported in questionnaires

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026